bucindolol has been researched along with Disease Exacerbation in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aleong, RG; Bristow, MR; Davis, G; Sauer, WH | 1 |
Remme, WJ | 1 |
Francis, GS; Sarraf, M | 1 |
Bristow, MR; Deedwania, P; Domanski, M; Follmann, D; Ghali, JK; Gilbert, E; Haffner, S; Katz, R; Krause-Steinrauf, H; Lindenfeld, J; Lowes, BD; Martin, W; McGrew, F | 1 |
Czuriga, I; Edes, I | 1 |
2 review(s) available for bucindolol and Disease Exacerbation
Article | Year |
---|---|
β-blockers in stage B: a precursor of heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Benzazepines; Bisoprolol; Carbazoles; Cardiovascular System; Carvedilol; Disease Progression; Heart Failure; Heart Ventricles; Humans; Ivabradine; Propanolamines; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2012 |
[Role of beta-blockers in the treatment of chronic heart heart failure].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Controlled Clinical Trials as Topic; Disease Progression; Drug Administration Schedule; Heart Failure; Humans; Metoprolol; Myocardial Contraction; Patient Selection; Propanolamines; Survival Rate; Ventricular Dysfunction, Left; Ventricular Function, Left | 2001 |
1 trial(s) available for bucindolol and Disease Exacerbation
Article | Year |
---|---|
New-onset atrial fibrillation predicts heart failure progression.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Disease Progression; Female; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Propanolamines; Proportional Hazards Models; Risk Factors; Ventricular Dysfunction, Left | 2014 |
2 other study(ies) available for bucindolol and Disease Exacerbation
Article | Year |
---|---|
Which beta-blocker is most effective in heart failure?
Topics: Adrenergic beta-Antagonists; Animals; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Comorbidity; Diabetes Mellitus; Disease Progression; Ethanolamines; Heart Failure; Humans; Lung Diseases, Obstructive; Metoprolol; Myocardial Infarction; Nebivolol; Propanolamines; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling | 2010 |
The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Cause of Death; Diabetes Complications; Disease Progression; Female; Heart Failure; Heart Transplantation; Hospitalization; Humans; Male; Middle Aged; Prognosis; Propanolamines; Proportional Hazards Models; Retrospective Studies; Risk Factors; Severity of Illness Index; Survival Analysis; Treatment Outcome; Ventricular Function | 2003 |